Paper17455990
Characteristics and impact of drug detailing for gabapentin.
Steinman MA and 4 others. PLoS Med, 2007. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Characteristics and impact of drug detailing for gabapentin. Papers, record 17455990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17455990
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amines | Major topic |
| Cyclohexanecarboxylic Acids | Major topic |
| Drug Industry | Major topic |
| Marketing | Major topic |
| gamma-Aminobutyric Acid | Major topic |
| Gabapentin | |
| Humans | |
| Physicians |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K07 AG000912 | NIA NIH HHS | United States | K07AG000912 | PubMed and NIH | NIH RePORTER |
| K24 AR052667 | NIAMS NIH HHS | United States | K24AR052667 | PubMed and NIH | NIH RePORTER |
| Z01 AG000912 | Intramural NIH HHS | United States | K07AG000912 | PubMed and NIH | NIH RePORTER |
| Z01AG000912 | NIH | NIH RePORTER |
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2218627 | Patterns of preference for information sources in the adoption of new drugs by specialists. | Soc Sci Med | 1990 | https://conductscience.org/library/papers/2218627 | PubMed |
| 2 | 2398609 | Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. | JAMA | 1990 | https://conductscience.org/library/papers/2398609 | PubMed |
| 3 | 8455108 | The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. | J Gen Intern Med | 1993 | https://conductscience.org/library/papers/8455108 | PubMed |
| 4 | 8221424 | Interactions between physicians and the pharmaceutical industry: what does the literature say? | CMAJ | 1993 | https://conductscience.org/library/papers/8221424 | PubMed |
| 5 | 8204336 | Attitudes of general practitioners in New Zealand to pharmaceutical representatives. | Br J Gen Pract | 1994 | https://conductscience.org/library/papers/8204336 | PubMed |
| 6 | 7823228 | Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion. | J Gen Intern Med | 1994 | https://conductscience.org/library/papers/7823228 | PubMed |
| 7 | 7715044 | The accuracy of drug information from pharmaceutical sales representatives. | JAMA | 1995 | https://conductscience.org/library/papers/7715044 | PubMed |
| 8 | 7641153 | Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. | CMAJ | 1995 | https://conductscience.org/library/papers/7641153 | PubMed |
| 9 | 8829983 | Teaching information mastery: evaluating information provided by pharmaceutical representatives. | Fam Med | 1995 | https://conductscience.org/library/papers/8829983 | PubMed |
| 10 | 10159647 | Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study. | Health Mark Q | 1996 | https://conductscience.org/library/papers/10159647 | PubMed |
| 11 | 8769907 | Physicians, pharmaceutical sales representatives, and the cost of prescribing. | Arch Fam Med | 1996 | https://conductscience.org/library/papers/8769907 | PubMed |
| 12 | 8911290 | Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. | CMAJ | 1996 | https://conductscience.org/library/papers/8911290 | PubMed |
| 13 | 8945688 | Characteristics of materials distributed by drug companies. An evaluation of appropriateness. | J Gen Intern Med | 1996 | https://conductscience.org/library/papers/8945688 | PubMed |
| 14 | 9154366 | What information do physicians receive from pharmaceutical representatives? | Can Fam Physician | 1997 | https://conductscience.org/library/papers/9154366 | PubMed |
| 15 | 9346461 | Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives. | J Gen Intern Med | 1997 | https://conductscience.org/library/papers/9346461 | PubMed |
| 16 | 9447476 | The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians. | J Clin Pharm Ther | 1997 | https://conductscience.org/library/papers/9447476 | PubMed |
| 17 | 9595344 | Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners? | Int J Health Serv | 1998 | https://conductscience.org/library/papers/9595344 | PubMed |
| 18 | 9673741 | Commercial detailing techniques used by pharmaceutical representatives to influence prescribing. | Aust N Z J Med | 1998 | https://conductscience.org/library/papers/9673741 | PubMed |
| 19 | 9703533 | Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. | BMJ | 1998 | https://conductscience.org/library/papers/9703533 | PubMed |
| 20 | 10514174 | Reasons for not seeing drug representatives. They should be seen because they are a good resource. | BMJ | 1999 | https://conductscience.org/library/papers/10514174 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42571643 | Money, Meals, and Marketing in Medicine: A 13-Year Follow-Up Survey of Physicians. | Clin Pharmacol Ther | 2026 | https://conductscience.org/library/papers/42571643 | PubMed |
| 41115759 | Industry Interactions at Medical Conferences: Representatives' Credentials and the Disclosure of Data Limitations Influence Clinician Perceptions. | J Am Board Fam Med | 2025 | https://conductscience.org/library/papers/41115759 | PubMed |
| 40475212 | What did the scientific literature learn from internal company documents in the pharmaceutical industry? A scoping review. | Cochrane Evid Synth Methods | 2023 | https://conductscience.org/library/papers/40475212 | PubMed |
| 26812151 | Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012. | PLoS Med | 2016 | https://conductscience.org/library/papers/26812151 | PubMed |
| 25556909 | Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011. | Br J Clin Pharmacol | 2015 | https://conductscience.org/library/papers/25556909 | PubMed |
| 24800999 | Who has used internal company documents for biomedical and public health research and where did they find them? | PLoS One | 2014 | https://conductscience.org/library/papers/24800999 | PubMed |
| 23205141 | Doctors' opinions of information provided by Libyan pharmaceutical company representatives. | Libyan J Med | 2012 | https://conductscience.org/library/papers/23205141 | PubMed |
| 23104048 | Sorrell v. IMS Health: issues and opportunities for informaticians. | J Am Med Inform Assoc | 2013 | https://conductscience.org/library/papers/23104048 | PubMed |
| 23002397 | A survey of pharmaceutical company representative interactions with doctors in Libya. | Libyan J Med | 2012 | https://conductscience.org/library/papers/23002397 | PubMed |
| 22899894 | Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures. | PLoS Med | 2012 | https://conductscience.org/library/papers/22899894 | PubMed |
| 22505850 | The imperative to share clinical study reports: recommendations from the Tamiflu experience. | PLoS Med | 2012 | https://conductscience.org/library/papers/22505850 | PubMed |
| 21483716 | Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints. | PLoS Med | 2011 | https://conductscience.org/library/papers/21483716 | PubMed |
| 21233426 | The inverse benefit law: how drug marketing undermines patient safety and public health. | Am J Public Health | 2011 | https://conductscience.org/library/papers/21233426 | PubMed |
| 20976098 | Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. | PLoS Med | 2010 | https://conductscience.org/library/papers/20976098 | PubMed |
| 20840443 | Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07. | Br J Clin Pharmacol | 2010 | https://conductscience.org/library/papers/20840443 | PubMed |
| 20574555 | A survey of german physicians in private practice about contacts with pharmaceutical sales representatives. | Dtsch Arztebl Int | 2010 | https://conductscience.org/library/papers/20574555 | PubMed |
| 20388211 | Reporting bias in medical research - a narrative review. | Trials | 2010 | https://conductscience.org/library/papers/20388211 | PubMed |
| 20195173 | The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion. | Med Care | 2010 | https://conductscience.org/library/papers/20195173 | PubMed |
| 20162413 | Unbalanced reporting of benefits and harms in abstracts on rofecoxib. | Eur J Clin Pharmacol | 2010 | https://conductscience.org/library/papers/20162413 | PubMed |
| 19885393 | Mandatory disclosure of pharmaceutical industry-funded events for health professionals. | PLoS Med | 2009 | https://conductscience.org/library/papers/19885393 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17455990
GET https://conductscience.org/api/papers/v1/17455990/references?page=2